These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 5723266)
1. [Inveestigation of the inhibition of fibrinolysis using epsilon-aminocapronic acid]. Stenszky E; Aszódi L; Hatvani I Acta Pharm Hung; 1968 Jun; 38(2):191-6. PubMed ID: 5723266 [No Abstract] [Full Text] [Related]
2. [On the fibrinolytic activity of the plasma of thrombopenic patients and the effect of corticoids and epsilon-aminocaproic acid]. Pileggi JE Sangre (Barc); 1967; 12(4):375-82. PubMed ID: 5614843 [No Abstract] [Full Text] [Related]
3. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus). Gogjian MA; Barry KJ; Stein BM Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767 [TBL] [Abstract][Full Text] [Related]
4. [Effect of epsilon-aminocapronic acid on fibrinolysis of euglobulins activated by endogenous activators of plasminogen]. Chmielewski J Pol Tyg Lek; 1965 Jul; 20(27):990-1. PubMed ID: 5840160 [No Abstract] [Full Text] [Related]
6. [Comparative studies on the fibrinolysis inhibitors AMCHA, epsilon-ACA and PAMBA]. Fischer M Wien Z Inn Med; 1966 Apr; 47(4):143-53. PubMed ID: 6005160 [No Abstract] [Full Text] [Related]
7. Inhibition of gastric plasmin activity by epsilon-aminocaproic acid. Thomson JM; Turner L; Poller L Ann R Coll Surg Engl; 1973 Dec; 53(6):340-7. PubMed ID: 4271260 [No Abstract] [Full Text] [Related]
8. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA). Lukasiewicz H; Niewiarowski S Thromb Diath Haemorrh; 1968 Jul; 19(3):584-92. PubMed ID: 4236825 [No Abstract] [Full Text] [Related]
9. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro]. Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517 [No Abstract] [Full Text] [Related]
10. [Inhibitors of fibrinolysis. (Our experience with epsilon-aminocaproic acid and the Kunitz inhibitor)]. Babío San Salvador JL; Iriarte Ezcurdia JA; Ezcurra Cebreiro JM Rev Clin Esp; 1965 Nov; 99(4):249-52. PubMed ID: 5863279 [No Abstract] [Full Text] [Related]
11. [The development of fibrinolysis inhibitors]. Markwardt F Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):5-14. PubMed ID: 4173881 [No Abstract] [Full Text] [Related]
12. [Antifibrinolytic agents, a new class of drugs]. Markwardt F Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412 [No Abstract] [Full Text] [Related]
13. [Comparison of antifibrinolytic effects of epsilon-aminocaproic acid and enzyme inhibitors in the surgery of portal hypertension]. Lande M; Clot-Paimboeuf C; Dentan T Presse Med (1893); 1971 Jan; 79(1):15-6. PubMed ID: 5539954 [No Abstract] [Full Text] [Related]
14. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures. Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948 [No Abstract] [Full Text] [Related]
15. [The inhibitors of fibrinolysis: new information on antifibrinolytic agents]. Giacomazzi G Haematologica; 1968; 53(7):489-533. PubMed ID: 4976851 [No Abstract] [Full Text] [Related]
16. [On the effect of a new synthetic inhibitor of the fibrinolytic system]. Fischer M; Pavlu C Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440 [No Abstract] [Full Text] [Related]
18. [Localized fibrinolysis of the tonsil and antiplasmin compounds]. Asaga M; Okamoto M; Asaga H; Kimura M Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):462-3. PubMed ID: 5106660 [No Abstract] [Full Text] [Related]
19. [Pharmacological study of some inhibitors of fibrinolysis]. Gavrilov AP Farmakol Toksikol; 1967; 30(4):460-3. PubMed ID: 5598902 [No Abstract] [Full Text] [Related]
20. [Inhibitor of fibrinolysis from pancreas pantrypin]. Lakin KM; Efimov VS; Polonskaia LB Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603 [No Abstract] [Full Text] [Related] [Next] [New Search]